Literature DB >> 23340854

Impact of preoperative serum interleukin-2 receptor alpha levels on survival and its correlation with clinicopathological parameters in colorectal cancer.

Xiaomei Liu1, Yinxu Zhang, Junhua Zhang, Zhitu Zhu, Minwen Ha, Chunying Liu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23340854     DOI： 10.1007/s00384-012-1638-9

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN： 0179-1958            Impact factor:   2.571


× No keyword cloud information.
  4 in total

1.  Serum soluble interleukin-2 receptor level and immunophenotype are prognostic factors for patients with diffuse large B-cell lymphoma.

Authors:  Toshiaki Morito; Megumu Fujihara; Hideki Asaoku; Akira Tari; Yasuharu Sato; Kouichi Ichimura; Takehiro Tanaka; Katsuyoshi Takata; Maiko Tamura; Tadashi Yoshino
Journal:  Cancer Sci       Date:  2009-04-22       Impact factor: 6.716

2.  Effect of oxaliplatin, fluorouracil, and leucovorin with or without cetuximab on survival among patients with resected stage III colon cancer: a randomized trial.

Authors:  Steven R Alberts; Daniel J Sargent; Suresh Nair; Michelle R Mahoney; Margaret Mooney; Stephen N Thibodeau; Thomas C Smyrk; Frank A Sinicrope; Emily Chan; Sharlene Gill; Morton S Kahlenberg; Anthony F Shields; James T Quesenberry; Thomas A Webb; Gist H Farr; Barbara A Pockaj; Axel Grothey; Richard M Goldberg
Journal:  JAMA       Date:  2012-04-04       Impact factor: 56.272

3.  Serum soluble interleukin-2 receptor concentrations as an independent prognostic marker in head and neck cancer.

Authors:  E Tartour; V Mosseri; T Jouffroy; L Deneux; C Jaulerry; F Brunin; W H Fridman; J Rodriguez
Journal:  Lancet       Date:  2001-04-21       Impact factor: 79.321

Review 4.  Colorectal cancer.

Authors:  Jürgen Weitz; Moritz Koch; Jürgen Debus; Thomas Höhler; Peter R Galle; Markus W Büchler
Journal:  Lancet       Date:  2005 Jan 8-14       Impact factor: 79.321
  4 in total
  2 in total

1.  Joint prognostic effect of obesity and chronic systemic inflammation in patients with metastatic colorectal cancer.

Authors:  Manasi S Shah; David R Fogelman; Kanwal Pratap Singh Raghav; John V Heymach; Hai T Tran; Zhi-Qin Jiang; Scott Kopetz; Carrie R Daniel
Journal:  Cancer       Date:  2015-05-14       Impact factor: 6.860

2.  A prognostic model for colorectal cancer based on CEA and a 48-multiplex serum biomarker panel.

Authors:  Camilla Böckelman; Caj Haglund; Kajsa Björkman; Sirpa Jalkanen; Marko Salmi; Harri Mustonen; Tuomas Kaprio; Henna Kekki; Kim Pettersson
Journal:  Sci Rep       Date:  2021-02-22       Impact factor: 4.379
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.